Properties (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Genomics
|
| gptkbp:aimsTo |
Improve patient outcomes
|
| gptkbp:appliesTo |
Personalized medicine
|
| gptkbp:canLeadTo |
Targeted therapies
Preventive strategies |
| gptkbp:focusesOn |
Genetic testing
|
| gptkbp:hasCollaboratedWith |
Research institutions
Healthcare_providers |
| https://www.w3.org/2000/01/rdf-schema#label |
Clinical Genomics
|
| gptkbp:involves |
Data analysis
|
| gptkbp:isAttendedBy |
Research funding
Technological innovation Collaborative studies |
| gptkbp:isChallengedBy |
Ethical considerations
Data privacy issues Regulatory hurdles Insurance coverage issues Interpretation of variants Limited access to testing |
| gptkbp:isCounteredBy |
Treatment decisions
|
| gptkbp:isEnhancedBy |
Artificial intelligence
|
| gptkbp:isEvaluatedBy |
Cost-effectiveness
Patient satisfaction Clinical outcomes |
| gptkbp:isFacilitatedBy |
Interdisciplinary teams
Data sharing Collaboration between disciplines |
| gptkbp:isInformedBy |
Family history
Clinical guidelines Genetic counseling |
| gptkbp:isLinkedTo |
Genetic disorders
Familial syndromes Hereditary cancers |
| gptkbp:isPartOf |
Precision medicine
|
| gptkbp:isPromotedBy |
Public health initiatives
Awareness campaigns |
| gptkbp:isRegulatedBy |
Health authorities
|
| gptkbp:isSupportedBy |
Technological advancements
Clinical trials Funding agencies |
| gptkbp:isUsedIn |
Oncology
Rare disease diagnosis |
| gptkbp:isUtilizedIn |
Pharmacogenomics
Prenatal testing Tumor profiling Carrier screening |
| gptkbp:isVisitedBy |
Geneticists
Molecular biologists |
| gptkbp:mayHave |
Genetic mutations
|
| gptkbp:requires |
Bioinformatics expertise
|
| gptkbp:utilizes |
Next-generation sequencing
|